Cargando…

Appropriate Delivery of Antitachyarrhythmia Therapy Despite Magnet Placement Over Implanted Cardioverter-Defibrillator: A Case Report

The fundamental perioperative concern for patients with implantable cardioverter-defibrillators (ICDs) is the potential for electromagnetic interference (EMI) from monopolar electrosurgery. The ICD may interpret electromagnetic signals as a tachyarrhythmia and deliver an inappropriate shock to the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gajendran, Vishal K., Contractor, Tahmeed, Tone, Ryan C., Mascetti, Carin R., McCabe, Melissa D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162221/ https://www.ncbi.nlm.nih.gov/pubmed/33999010 http://dx.doi.org/10.1213/XAA.0000000000001465

Ejemplares similares

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

Double trouble: Management of implantable cardioverter-defibrillator infection in the setting of severe aortic stenosis
por: Contractor, Tahmeed, et al.
Publicado: (2019)

Azygos Vein Lead Implantation For High Defibrillation Thresholds In Implantable Cardioverter Defibrillator Placement
por: Kommuri, Naga VA, et al.
Publicado: (2010)

Predictors of appropriate ICD therapy in patients with implantable cardioverter-defibrillator
por: Dehghani, Mohammad Reza, et al.
Publicado: (2006)

Real‐time echocardiographic guidance for confirming septal placement of right ventricular leads: A pilot study
por: Yan, Manshu, et al.
Publicado: (2021)

Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy
por: Apiyasawat, Sirin, et al.
Publicado: (2014)

Baseline and Dynamic Risk Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy
por: Wu, Katherine C., et al.
Publicado: (2020)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
por: Kishihara, Jun, et al.
Publicado: (2016)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Appropriate therapy for implantable cardioverter defibrillators used as primary versus secondary prophylaxis
por: Thuraiaiyah, J, et al.
Publicado: (2023)

A Rare, Late Complication after Automated Implantable Cardioverter-Defibrillator Placement
por: Shapiro, Michael, et al.
Publicado: (2004)

Minimally invasive, pericardial implantable cardioverter-defibrillator placement in a young child
por: Maki, Wakana, et al.
Publicado: (2017)

Substernal subcutaneous implantable cardioverter-defibrillator lead placement for the management of inappropriate shocks
por: Do, Khuyen, et al.
Publicado: (2019)

Approaches to Minimizing Periprocedural Complications During Subcutaneous Implantable Cardioverter-defibrillator Placement
por: Vedachalam, Srikanth, et al.
Publicado: (2020)

Perioperative and postoperative pain in patients undergoing subcutaneous implantable cardioverter-defibrillator placement
por: Bisignani, A, et al.
Publicado: (2023)

Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up
por: Gandhi, Kaushang, et al.
Publicado: (2010)

Acute ST-Segment Elevation Myocardial Infarction as a Rare Postoperative Complication of Biventricular Implantable Cardioverter-Defibrillator Placement
por: Phogat, Vishal, et al.
Publicado: (2022)

Appropriate Implantable Cardioverter-Defibrillator Therapies Delivered 5 Years After End of Service
por: Yuyun, Matthew F., et al.
Publicado: (2020)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria
por: An, Yoshimori, et al.
Publicado: (2017)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Anesthesia in a Child with Newly Diagnosed Hypertrophic Cardiomyopathy for Placement of Implantable Cardioverter Defibrillator
por: Kumar, Rajnish, et al.
Publicado: (2018)

Brugada Syndrome: The Role of Risk Stratification in Selecting Patients for Implantable Cardioverter-defibrillator Placement
por: Mankbadi, Michael, et al.
Publicado: (2018)

Acquired Pediatric Right Diaphragmatic Hernia Following Automatic Implantable Cardioverter-defibrillator Placement
por: Ottoboni, Adria, et al.
Publicado: (2019)

Right-sided subcutaneous implantable cardioverter-defibrillator placement in a patient with “acquired mesocardia”
por: Prousi, George S., et al.
Publicado: (2022)

Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator
por: van Barreveld, M., et al.
Publicado: (2017)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

Epidural Blood Patch Placement with Patient Wearing Wearable Cardioverter Defibrillator: To be or Not to be
por: Gupta, Deepak
Publicado: (2023)

Adult-onset verrucous epidermal nevus overlying an implanted cardioverter-defibrillator
por: AlFada, Mohammed A., et al.
Publicado: (2023)

Predictors of appropriate therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death
por: Ahmed, Imdad, et al.
Publicado: (2010)

Impact of Moderate to Severe Renal Impairment on Mortality and Appropriate Shocks in Patients with Implantable Cardioverter Defibrillators
por: Alla, Venkata M., et al.
Publicado: (2010)

Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy
por: Rayatzadeh, Hussein, et al.
Publicado: (2013)

Appropriate and Inappropriate Implantable Cardioverter Defibrillators Therapies in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Patients
por: Al-Ghamdi, Bandar, et al.
Publicado: (2018)

Paradox of Appropriate Implantable Cardioverter‐Defibrillator Therapy: Saving Lives But Revealing an Increased Mortality Risk
por: Aleong, Ryan G., et al.
Publicado: (2017)

Factors associated with implantable cardioverter defibrillators appropriate therapy in cardiac sarcoidosis: a meta-analysis
por: Azoulay, Levi-Dan, et al.
Publicado: (2020)

Appropriateness of Prescription and Safety of Wearable Cardioverter Defibrillators: A Single-center Experience
por: Sundhu, Murtaza, et al.
Publicado: (2019)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_64kkuakvn7tmkl0lpmfgq3nh8v